booster

in Health care

USFDA authorizes second Omicron-updated COVID booster for older adults

by April 20, 2023, 10:20 am

US: The U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those with a weak immune system. The agency also said the updated shots from Pfizer-BioNTech and Moderna would become the new primary COVID vaccine, and withdrew its emergency-use authorization for the older messenger RNA […] More
Newsletter

Want more stuff like this?

Get the best viral stories straight into your inbox!

Email address:

Don't worry, we don't spam
in Health care

Surge in COVID-19 cases: Booster shot to prevent infection may do more harm than good, says AIIMS doctor

by April 17, 2023, 10:40 am

New Delhi: In the wake of the recent rise in COVID-19 cases, although many experts are advising people to take maximum precautions and also booster doses, AIIMS doctor Dr Sanjay Rai is of the opinion that at this point of time, a booster dose of the vaccine can do more harm than good. In the […] More
in Health care

SII Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose

by April 12, 2023, 5:51 am

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Instituteâ€™s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. Covovax is likely to be available on the portal in […] More
in Health care

COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults

by April 4, 2023, 6:11 am

New Delhi: Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its Covid-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute […] More
in Health care

Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years

by March 15, 2023, 6:27 am

New York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to provide a single booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 6 months through 4 years of age (also referred to as under 5 years of age) at […] More